| Oseremen Lauretta Okojie, NP | |
|
4 Cypress Grove Ct, Owings Mills, MD 21117-6703 | |
| (443) 768-7995 | |
| Not Available |
| Full Name | Oseremen Lauretta Okojie |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4 Cypress Grove Ct, Owings Mills, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114400066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R172420 (Maryland) | Primary |
| Entity Name | Health Express Of Maryland Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356805154 PECOS PAC ID: 4789911421 Enrollment ID: O20190805000084 |
News Archive
Technological innovations, multiple genres, online gaming and mobile apps have led gaming to become big business. Call of Duty Black Ops sold 1.4 million copies and registered 2.6 million Xbox Live players on launch day. Adolescents increasingly use gaming for a significant part of their leisure time.
New research reveals a causal association between elevated body mass index (BMI) and increased risk of gallstone disease. Results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show women are at greater risk of developing gallstones.
The John Theurer Cancer Center at Hackensack University Medical Center unveiled a new $130-million, 155,000-square-foot comprehensive cancer facility that will enhance the cancer center's ability to deliver multidisciplinary extraordinary care, best-in-class clinical quality, and cutting-edge research. The doors will open for patients in January 2011.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 2 days ago
| Entity Name | Medical Maryland Star Choice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770190647 PECOS PAC ID: 1153731765 Enrollment ID: O20201111000857 |
News Archive
Technological innovations, multiple genres, online gaming and mobile apps have led gaming to become big business. Call of Duty Black Ops sold 1.4 million copies and registered 2.6 million Xbox Live players on launch day. Adolescents increasingly use gaming for a significant part of their leisure time.
New research reveals a causal association between elevated body mass index (BMI) and increased risk of gallstone disease. Results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show women are at greater risk of developing gallstones.
The John Theurer Cancer Center at Hackensack University Medical Center unveiled a new $130-million, 155,000-square-foot comprehensive cancer facility that will enhance the cancer center's ability to deliver multidisciplinary extraordinary care, best-in-class clinical quality, and cutting-edge research. The doors will open for patients in January 2011.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 2 days ago
| Entity Name | Cathy Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063171007 PECOS PAC ID: 6305238742 Enrollment ID: O20220118000006 |
News Archive
Technological innovations, multiple genres, online gaming and mobile apps have led gaming to become big business. Call of Duty Black Ops sold 1.4 million copies and registered 2.6 million Xbox Live players on launch day. Adolescents increasingly use gaming for a significant part of their leisure time.
New research reveals a causal association between elevated body mass index (BMI) and increased risk of gallstone disease. Results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show women are at greater risk of developing gallstones.
The John Theurer Cancer Center at Hackensack University Medical Center unveiled a new $130-million, 155,000-square-foot comprehensive cancer facility that will enhance the cancer center's ability to deliver multidisciplinary extraordinary care, best-in-class clinical quality, and cutting-edge research. The doors will open for patients in January 2011.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oseremen Lauretta Okojie, NP 4 Cypress Grove Ct, Owings Mills, MD 21117-6703 Ph: (443) 768-7995 | Oseremen Lauretta Okojie, NP 4 Cypress Grove Ct, Owings Mills, MD 21117-6703 Ph: (443) 768-7995 |
News Archive
Technological innovations, multiple genres, online gaming and mobile apps have led gaming to become big business. Call of Duty Black Ops sold 1.4 million copies and registered 2.6 million Xbox Live players on launch day. Adolescents increasingly use gaming for a significant part of their leisure time.
New research reveals a causal association between elevated body mass index (BMI) and increased risk of gallstone disease. Results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show women are at greater risk of developing gallstones.
The John Theurer Cancer Center at Hackensack University Medical Center unveiled a new $130-million, 155,000-square-foot comprehensive cancer facility that will enhance the cancer center's ability to deliver multidisciplinary extraordinary care, best-in-class clinical quality, and cutting-edge research. The doors will open for patients in January 2011.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 2 days ago
Adedayo Temitope Omobo, CRNP-PMH Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10999 Red Run Blvd Ste 205, Owings Mills, MD 21117 Phone: 240-462-7690 | |
Jennifer Pullmann, RN, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 Crossroads Dr, Suite 205, Owings Mills, MD 21117 Phone: 410-602-7792 Fax: 410-602-9889 | |
Amanda Harner, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Campus Cir, Owings Mills, MD 21117 Phone: 443-352-4200 | |
Samson Olanrewaju Arigbamu, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10451 Mill Run Cir Ste 730, Owings Mills, MD 21117 Phone: 410-303-0057 Fax: 410-358-4938 | |
Nkiru Nonso-ekweozoh, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9419 Common Brook Rd Ste 208, Owings Mills, MD 21117 Phone: 410-864-0211 Fax: 410-618-4163 | |
Judith W. Ryan, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10989 Red Run Blvd, Suite 208, Owings Mills, MD 21117 Phone: 410-654-8602 Fax: 410-654-8709 | |
Ms. Natasha L Loving, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4554 Hidden Stream Ct, Owings Mills, MD 21117 Phone: 443-373-6081 |